![Steen Lisby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Steen Lisby worked as the Vice President & Head-Medical at Genmab A from 2015 to 2017.
He then joined Y-mAbs Therapeutics, Inc. as the Chief Scientific Officer & Senior Vice President in 2017.
Prior to his industry roles, Dr. Lisby obtained a doctorate degree from the University of Copenhagen.
Former positions of Steen Lisby
| Companies | Position | End |
|---|---|---|
| YMAS THER | Chief Tech/Sci/R&D Officer | 18/04/2024 |
| GENMAB A/S | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Training of Steen Lisby
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Genmab A/S
 Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. Develops novel antibody therapeutics for oncology targets |
- Stock Market
- Insiders
- Steen Lisby
